ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings
ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2022年第二次临时股东大会决议公告 | 2022-12-29 | Chinese | |
| 第五届董事会第二十三次会议决议公告 | 2022-12-26 | Chinese | |
| 关于出售凯惠药业（上海）有限公司股权的进展公告 | 2022-12-26 | Chinese | |
| 关于受让珠海横琴中科建创投资合伙企业（有限合伙）合伙份额的公告 | 2022-12-19 | Chinese | |
| 关于聘任曾宪维先生为公司首席执行官（CEO）的公告 | 2022-12-13 | Chinese | |
| 关于独立董事辞职暨补选独立董事的公告 | 2022-12-13 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
15 filings
| |||||
| 36038649 | 2022年第二次临时股东大会决议公告 | 2022-12-29 | Chinese | ||
| 36038638 | 第五届董事会第二十三次会议决议公告 | 2022-12-26 | Chinese | ||
| 36038627 | 关于出售凯惠药业（上海）有限公司股权的进展公告 | 2022-12-26 | Chinese | ||
| 36038619 | 关于受让珠海横琴中科建创投资合伙企业（有限合伙）合伙份额的公告 | 2022-12-19 | Chinese | ||
| 36038603 | 关于聘任曾宪维先生为公司首席执行官（CEO）的公告 | 2022-12-13 | Chinese | ||
| 36038598 | 关于独立董事辞职暨补选独立董事的公告 | 2022-12-13 | Chinese | ||
| 36038587 | 独立董事候选人关于参加独立董事培训并取得独立董事资格证书的承诺函 | 2022-12-13 | Chinese | ||
| 36038580 | 关于召开2022年第二次临时股东大会的通知 | 2022-12-13 | Chinese | ||
| 36038568 | 第五届董事会第二十二次会议决议公告 | 2022-12-13 | Chinese | ||
| 36038557 | 独立董事提名人声明（杨凌） | 2022-12-13 | Chinese | ||
| 36038548 | 独立董事候选人声明（杨凌） | 2022-12-13 | Chinese | ||
| 36038540 | 独立董事关于第五届董事会第二十二次会议相关事项的独立意见 | 2022-12-13 | Chinese | ||
| 36038527 | 关于持股5%以上股东减持股份比例达到1%的公告 | 2022-11-22 | Chinese | ||
| 36131783 | 子公司管理制度 | 2022-10-26 | Chinese | ||
| 36131780 | 董事、监事和高级管理人员股份变动管理制度 | 2022-10-26 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
ChemPartner PharmaTech Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55161/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55161 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55161 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55161 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55161}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ChemPartner PharmaTech Co., Ltd. (id: 55161)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.